rs146972491

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001303256.3(MORC2):​c.1768C>T​(p.Leu590Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,613,832 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00075 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 3 hom. )

Consequence

MORC2
NM_001303256.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.18

Publications

1 publications found
Variant links:
Genes affected
MORC2 (HGNC:23573): (MORC family CW-type zinc finger 2) This gene encodes a member of the Microrchidia (MORC) protein superfamily. The encoded protein is known to regulate the condensation of heterochromatin in response to DNA damage and play a role in repressing transcription. The protein has been found to regulate the activity of ATP citrate lyase via specific interaction with this enzyme in the cytosol of lipogenic breast cancer cells. The protein also plays a role in lipogenesis and adipocyte differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2016]
MORC2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease axonal type 2Z
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 22-30935292-G-A is Benign according to our data. Variant chr22-30935292-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.18 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000749 (114/152116) while in subpopulation NFE AF = 0.00137 (93/68020). AF 95% confidence interval is 0.00114. There are 0 homozygotes in GnomAd4. There are 47 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 114 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001303256.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MORC2
NM_001303256.3
MANE Select
c.1768C>Tp.Leu590Leu
synonymous
Exon 18 of 26NP_001290185.1Q9Y6X9-1
MORC2
NM_001303257.2
c.1768C>Tp.Leu590Leu
synonymous
Exon 18 of 26NP_001290186.1Q9Y6X9
MORC2
NM_014941.3
c.1582C>Tp.Leu528Leu
synonymous
Exon 19 of 27NP_055756.1Q9Y6X9-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MORC2
ENST00000397641.8
TSL:5 MANE Select
c.1768C>Tp.Leu590Leu
synonymous
Exon 18 of 26ENSP00000380763.2Q9Y6X9-1
MORC2
ENST00000215862.8
TSL:1
c.1582C>Tp.Leu528Leu
synonymous
Exon 19 of 27ENSP00000215862.4Q9Y6X9-2
MORC2
ENST00000924805.1
c.1768C>Tp.Leu590Leu
synonymous
Exon 18 of 26ENSP00000594864.1

Frequencies

GnomAD3 genomes
AF:
0.000749
AC:
114
AN:
152116
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00137
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000614
AC:
154
AN:
250994
AF XY:
0.000649
show subpopulations
Gnomad AFR exome
AF:
0.000371
Gnomad AMR exome
AF:
0.000319
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000925
Gnomad NFE exome
AF:
0.00111
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.00145
AC:
2126
AN:
1461716
Hom.:
3
Cov.:
31
AF XY:
0.00138
AC XY:
1003
AN XY:
727128
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33474
American (AMR)
AF:
0.000403
AC:
18
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000232
AC:
20
AN:
86192
European-Finnish (FIN)
AF:
0.000262
AC:
14
AN:
53416
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00180
AC:
1997
AN:
1111966
Other (OTH)
AF:
0.00114
AC:
69
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
113
226
339
452
565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000749
AC:
114
AN:
152116
Hom.:
0
Cov.:
31
AF XY:
0.000632
AC XY:
47
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41420
American (AMR)
AF:
0.000524
AC:
8
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4818
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00137
AC:
93
AN:
68020
Other (OTH)
AF:
0.000479
AC:
1
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00111
Hom.:
0
Bravo
AF:
0.000733
EpiCase
AF:
0.00131
EpiControl
AF:
0.00119

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Charcot-Marie-Tooth disease axonal type 2Z (2)
-
-
2
not provided (2)
-
-
1
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (1)
-
-
1
MORC2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
12
DANN
Benign
0.78
PhyloP100
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146972491; hg19: chr22-31331279; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.